Brian Bergmark, MD, FACC

Brian Bergmark

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Janssen Pharmaceuticals, Inc(SIGNIFICANT), Quark Pharmaceuticals(MODEST), Daiichi Sankyo(MODEST), Abbott Vascular(SIGNIFICANT), Philips(MODEST), Servier(SIGNIFICANT), Abiomed(MODEST) RESEARCH/RESEARCH GRANTS: AstraZeneca Pharmaceuticals(NONE), Pfizer Inc(NONE), Ionis(NONE)

View Full Disclosure